Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$2.41 - $4.81 $129,701 - $258,864
-53,818 Reduced 21.2%
200,000 $770,000
Q1 2023

May 15, 2023

SELL
$2.08 - $4.79 $33,658 - $77,511
-16,182 Reduced 5.99%
253,818 $766,000
Q4 2022

Feb 14, 2023

SELL
$1.86 - $3.54 $55,800 - $106,200
-30,000 Reduced 10.0%
270,000 $553,000
Q3 2022

Nov 14, 2022

SELL
$3.82 - $5.61 $38,200 - $56,100
-10,000 Reduced 3.23%
300,000 $1.04 Million
Q2 2022

Aug 15, 2022

BUY
$1.85 - $4.21 $573,500 - $1.31 Million
310,000 New
310,000 $1.31 Million

About Decibel Therapeutics, Inc.


  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Newtyn Management, LLC Portfolio

Follow Newtyn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.